These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6895407)

  • 21. Species similarities and differences in pharmacokinetics.
    Lin JH
    Drug Metab Dispos; 1995 Oct; 23(10):1008-21. PubMed ID: 8654187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
    Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
    Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
    Nong A; McCarver DG; Hines RN; Krishnan K
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of propranolol, the beta-adrenergic receptor blocking agents (author's transl)].
    Lou YQ
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):167-70. PubMed ID: 7313673
    [No Abstract]   [Full Text] [Related]  

  • 30. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics.
    Fernández-Teruel C; Gonzalez-Alvarez I; Navarro-Fontestad C; García-Arieta A; Bermejo M; Casabó VG
    Eur J Pharm Sci; 2009 Jan; 36(1):147-56. PubMed ID: 19038335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of the systemic bioavailability of timolol in man.
    El-Rashidy R
    Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Absorption and oxidation rate of arginine and malate (author's transl)].
    Herbetz L; Adrian M; Bongers R; Büsing G; Reinauer H
    Leber Magen Darm; 1978 Dec; 8(6):347-52. PubMed ID: 739813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolism of the radioprotective agent aminopropyl-methyl-isothiourea in mice (author's transl)].
    Shia SS; Chen NC; Shen BF; Xu HY; Zhao SM; Shen WM
    Zhongguo Yao Li Xue Bao; 1980 Dec; 1(2):116-20. PubMed ID: 6461182
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacokinetics of metoprolol.
    Regårdh CG; Johnsson G
    Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
    [No Abstract]   [Full Text] [Related]  

  • 35. [Absorption and distribution of 1-(2,5-dichlorophenoxy)-3-tert-butylaminopropen-2-ol in aerosols].
    Stampf G; Benkö G; Bodó K
    Pharmazie; 1983 Jul; 38(7):481-2. PubMed ID: 6634916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kinetic of elimination of gitoxin by isolated and perfused rabbit liver: application of two models for compartmental analysis (author's transl)].
    Pellegrin P; Lesne M
    J Pharm Belg; 1979; 34(1):29-30. PubMed ID: 448628
    [No Abstract]   [Full Text] [Related]  

  • 37. [Statistics and comparative pharmacokinetics (author's transl)].
    Immich H; Vanderbeke O
    Med Klin; 1976 Sep; 71(38):1572-83. PubMed ID: 979869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of dimetacrine in rats (author's transl)].
    Neye J; Fenner H
    Arch Pharm (Weinheim); 1979 Jan; 312(1):2-12. PubMed ID: 426616
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on befunolol-metabolizing activities, especially on reducing activity (author's transl)].
    Tohno M; Yamamoto T; Kajikawa N; Ofuji T
    Yakugaku Zasshi; 1980 Apr; 100(4):443-51. PubMed ID: 7437132
    [No Abstract]   [Full Text] [Related]  

  • 40. Thin layer chromatography-fluorimetic estimation of tolamolol in human plasma.
    Stopher DA
    J Pharm Pharmacol; 1975 Feb; 27(2):133-4. PubMed ID: 237075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.